UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Alvedon250mgMunsonderTablett-SE-PLC-RA

Generated Narrative: RegulatedAuthorization Alvedon250mgMunsonderTablett-SE-PLC-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/16408

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100000478-00016408,http://ema.europa.eu/fhir/eurdId#2283; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Orodispersible tablet; indication = Alvedon 250 mg Munsönderfallande tablett är indicerat för huvudvärk, tandvärk, feber vid förkylningssjukdomar, menstruationssmärtor, muskel- och ledvärk, som analgetikum vid reumatiska smärtor, hyperpyrexi. Används av vuxna och barn över 3 år.; legalStatusOfSupply = Medicinal product not subject to medical prescription; classification = paracetamol

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2001-06-01

holder: Organization GlaxoSmithKline Consumer Healthcare ApS

Cases

-TypeDate[x]
*First Authorisation2001-06-01